HUANGSHAN-TOURISM
14.3.2022 12:38:06 CET | Business Wire | Press release
Huangshan again captured the imagination of guests at the 2022 ITB Berlin, the world's largest travel trade fair. This year’s virtual ITB Berlin, held from March 8 to 10, saw experts and industry representatives from around the world explore and discuss digital, resilient, and responsible solutions for the global tourism industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220314005401/en/
At the event, Huangshan Tourism Development Co., Ltd. (Huangshan Tourism) held a press conference and multimedia presentation to showcase the many attractions of Huangshan, including its prime location, unique landscapes, rich cultural heritage, and well-developed infrastructures to support local tourism.
The presentation covered six highlights that make Huangshan so appealing as a travel destination.
“Travel in Huangshan” showed its access to a transport network connecting key travel hubs in China. “The Beauty of Huangshan” put the spotlight on the spectacular scenery of Huangshan, from mountain landscapes and its characteristic pine trees to the nearby Taiping Lake. “The Food of Huangshan” gave a taste of the local Huizhou cuisine, one of China’s eight major cuisines. "Accommodation in Huangshan" provided an overview of the high-standard international tourist lodging. “Gifts from Huangshan" gave a glimpse of the unique local presents. Finally, “Culture in Huangshan” introduced the audience to the rich range of cultural and creative products that embody the handicraft, heritage, and traditions of the region.
The immersive format of the event and images of Huangshan Mountain and surrounding areas left a striking visual impact on the audience, again stimulating interest in Huangshan as a world-class travel destination that epitomizes the very best of China’s natural beauty and rich cultural heritage.
About Huangshan Tourism
Huangshan Tourism is one of China’s leading listed tourism companies. It covers a wide scope of business in and around the Mount Huangshan Scenic Area in China’s Anhui Province, from scenic spots and hotels to retail, catering, travel agencies, rural tourism, and other services.
Huangshan Tourism is committed to telling the story of Huangshan, Huizhou culture, and promoting the area as a top destination for both domestic and international tourists. The company carries out extensive overseas publicity and promotional activities, with over 150,000 followers across Facebook, Twitter, and Instagram. On New Year’s Day and during the Spring Festival this year, Huangshan Tourism once again caught the attention of global audiences with activities in Times Square in New York and Trafalgar Square in London.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220314005401/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan
VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release
Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise
Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release
Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to
Multi-Color Corporation Receives Court Approval of First Day Motions4.2.2026 21:30:00 CET | Press release
Obtains Interim Approval to Access $125 Million of DIP FinancingGlobal Operations and Services to Customers Continue in Normal Course Without Interruption During Restructuring Process; All Trade Vendors and Suppliers to be Paid in Full Multi-Color Corporation (“MCC” or the “Company”), a global leader in prime label solutions, today announced that it has received approval from the U.S. Bankruptcy Court for the District of New Jersey (the “Court”) for first day relief related to its prepackaged Chapter 11 filed on January 29, 2026. The approved relief affirms that the Company will operate in the normal course, pay all trade vendors and suppliers in full, and maintain a strong liquidity position during the restructuring. As part of this relief, the Court granted MCC immediate access to $125 million of $250 million in debtor-in-possession (“DIP”) new money financing, provided by certain holders of MCC’s secured first lien debt and its equity sponsor, CD&R. This funding will capitalize the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom